Naphazoline Hydrochloride and Pheniramine Maleate

Manufacturer: CVS Pharmacy | Akorn, Inc. | Akorn, Inc
Effective date: 2013-11-19
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: legacy-cache
Hydrated at: 2026-08-02 01:30:59

Label at a glance#

ProductNaphazoline Hydrochloride and Pheniramine Maleate

Active ingredientNaphazoline Hydrochloride, Pheniramine Maleate

Label structure11 sections

Indications and uses

Temporarily relieves itchy, red eyes due to: pollen ragweed grass animal hair and dander

Dosage and administration

adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day children under 6 years of age: consult a doctor

Contacts and useful links#

PhoneLabel contact1-800-579-8327

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Naphazoline Hydrochloride 0.025%

Pheniramine Maleate 0.3%

Purpose

OTC - PURPOSE SECTION

Redness reliever

Antihistamine

Uses

INDICATIONS & USAGE SECTION

Temporarily relieves itchy, red eyes due to:

pollen
ragweed
grass
animal hair and dander

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use if you are sensitive to any ingredient in this product

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

heart disease
high blood pressure
narrow angle glaucoma
trouble urinating due to an enlarged prostate gland

When using this product

OTC - WHEN USING SECTION

pupils may become enlarged temporarily
do not touch tip of container to any surface to avoid contamination
replace cap after each use
remove contact lenses before using
do not use if this solution changes color or becomes cloudy
overuse may cause more eye redness

Stop use and ask a doctor if

OTC - STOP USE SECTION

you feel eye pain
changes in vision occur
redness or irritation of the eye lasts
condition worsens or lasts more than 72 hours

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and marked reduction in body temperature.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 years of age and over: put 1 or 2 drops in the affected eye(s) up to four times a day
children under 6 years of age: consult a doctor

Other information

SPL UNCLASSIFIED SECTION

some users may experience a brief tingling sensation
store between 20° to 25°C (68° to 77°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Boric Acid and Sodium Borate buffer system preserved with Benzalkonium Chloride (0.01%) and Edetate Disodium Hydroxide and/or Hydrochloric Acid (to adjust pH) and Water for injection.

Questions or comments?

OTC - QUESTIONS SECTION

1-800-579-8327

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Container Label:

CVS Health_™ Logo

NDC 59779-365-01

Naphazoline HCl 0.025%

Pheniramine Maleate 0.3%

Ophthalmic Solution, USP

Allergy

Eye Drops

ANTIHISTAMINE &

REDNESS RELIEVER

RELIEVES REDNESS

& ITCHY EYES

STERILE

15 mL (0.5 FL OZ)

Principal Display Panel Text for Container Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel Text for Carton Label:

CVS Health_™ Logo Compare to the active

ingredient in Visine-A^®*

NDC 59779-365-01

Allergy

Eye Drops

Naphazoline HCl 0.025%

Pheniramine Maleate 0.3%

Ophthalmic Solution, USP

ANTIHISTAMINE &

REDNESS RELIEVER

RELIEVES REDNESS &

ITCHY EYES DUE TO:

• Pollen

• Ragweed

• Grass

• Animal hair

& dander

STERILE

15 mL (0.5 FL OZ)

Principal Display Panel Text for Carton Label

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59779-365-01	2020-10-23	C162847	48780-1	9d75b9cf-f5e1-f424-e053-dadaa90a57ce	a87837f8-1549-4b53-9cd9-e386f67e3195
59779-365-01	2020-01-31	C162847	48780-1	9d75b9cf-f5e1-f424-e053-dadaa90a57ce	a87837f8-1549-4b53-9cd9-e386f67e3195

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59779-365-01	ML - Milliliter	59779-365	0f116d73-2a71-46e7-af19-2f5a9508f5c3	1	2022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Naphazoline Hydrochloride	ACTIVE INGREDIENT	MZ1131787D	5
Pheniramine Maleate	ACTIVE INGREDIENT	NYW905655B	5
Naphazoline	ACTIVE MOIETY	H231GF11BV	5
Pheniramine	ACTIVE MOIETY	134FM9ZZ6M	5
Benzalkonium Chloride	INACTIVE INGREDIENT	F5UM2KM3W7	5
Boric Acid	INACTIVE INGREDIENT	R57ZHV85D4	5
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	5
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	5
Sodium Borate	INACTIVE INGREDIENT	91MBZ8H3QO	5
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	5
Water	INACTIVE INGREDIENT	059QF0KO0R	5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Naphazoline Hydrochloride and Pheniramine Maleate
Naphazoline Hydrochloride
Naphazoline
Pheniramine Maleate
Pheniramine
Boric Acid
Sodium Borate
Benzalkonium Chloride
Edetate Disodium
Sodium Hydroxide
Hydrochloric Acid
Water

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
59779-365	59779-365-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Naphazoline Hydrochloride	MZ1131787D	ACTIB
Pheniramine Maleate	NYW905655B	ACTIB
Boric Acid	R57ZHV85D4	IACT
Sodium Borate	91MBZ8H3QO	IACT
Benzalkonium Chloride	F5UM2KM3W7	IACT
Edetate Disodium	7FLD91C86K	IACT
Sodium Hydroxide	55X04QC32I	IACT
Hydrochloric Acid	QTT17582CB	IACT
Water	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 8 · 446 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	EMULSION / OPHTHALMIC	0.3 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRAMUSCULAR		306 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	TABLET, EXTENDED RELEASE / ORAL		10 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Boric Acid	BORIC ACID	R57ZHV85D4	JELLY / VAGINAL	1 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	LOTION / TOPICAL		21 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / SUBMUCOSAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRATUMOR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBARACHNOID	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION, SUSPENSION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	GEL / OPHTHALMIC		396 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SPONGE / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SOLUTION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Boric Acid	BORIC ACID	R57ZHV85D4	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	0.53 %w/v		Exact identifier — unii candidate 17 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Benzalkonium Chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	INJECTION / INTRALESIONAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / INTRACARDIAC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTABLE, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	AEROSOL, FOAM / RECTAL		2 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	TABLET, COATED / ORAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	TABLET / ORAL	2.32 mg		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION, CONCENTRATE / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	CONCENTRATE / ORAL	2.17 mg/1ml		Exact identifier — unii candidate 148 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	DROPS / AURICULAR (OTIC)	0.05 %w/w		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SPONGE / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION / INTRAMUSCULAR	10 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	POWDER, FOR SUSPENSION / ORAL		9 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Benzalkonium Chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION / RESPIRATORY (INHALATION)	0.02 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION, SUSPENSION / SOFT TISSUE		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	78.36 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	EMULSION / TOPICAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	CREAM / TOPICAL		38 mg	Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	SOLUTION / NASAL	100 mg/100ml		Exact identifier — unii candidate 77 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, COATED PELLETS / ORAL	0.01 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBMUCOSAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Edetate Disodium	EDETATE DISODIUM	7FLD91C86K	INJECTION / INTRAVASCULAR	0.48 mg		Exact identifier — unii candidate 77 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	SPRAY / RESPIRATORY (INHALATION)	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / ORAL		9120 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	GEL / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	ELIXIR / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / NASAL	20 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / RECTAL	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
Hydrochloric Acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	FILM / BUCCAL	0.09 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium Hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / ORAL	2 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC			2013-01-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202795-001	NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE	0.025%;0.3%	SOLUTION/DROPS / OPHTHALMIC	2013-01-24	`3a93d1ddd44b…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
6a8fcc9d-e3cf-4824-8532-c6a57521a86b			a87837f8-1549-4b53-9cd9-e386f67e3195	2020-10-23	Warnings	Exact identifier spl set id: a87837f8-1549-4b53-9cd9-e386f67e3195

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.